These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Barrière J; Gal J; Hoch B; Cassuto O; Leysalle A; Chamorey E; Borchiellini D Ann Oncol; 2021 May; 32(5):673-674. PubMed ID: 33529740 [No Abstract] [Full Text] [Related]
13. [COVID-19 vaccines and cancer patients: State of the art and guidelines summary]. Kharmoum S; El M'Rabet FZ Bull Cancer; 2021 May; 108(5):553-555. PubMed ID: 33902920 [No Abstract] [Full Text] [Related]
14. COVID-19 vaccines: call for global push to maintain efficacy. Stöhr K; Cox N Nature; 2021 Feb; 590(7844):36. PubMed ID: 33531701 [No Abstract] [Full Text] [Related]
15. The biosecurity of COVID-19 vaccines. Kantor IN Medicina (B Aires); 2020; 80 Suppl 6():104-106. PubMed ID: 33481741 [No Abstract] [Full Text] [Related]
19. Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2. Bilal M; Iqbal HMN Hum Vaccin Immunother; 2020 Dec; 16(12):3034-3042. PubMed ID: 32845742 [TBL] [Abstract][Full Text] [Related]
20. Understanding the determinants of acceptance of COVID-19 vaccines: a challenge in a fast-moving situation. Verger P; Peretti-Watel P Lancet Public Health; 2021 Apr; 6(4):e195-e196. PubMed ID: 33556329 [No Abstract] [Full Text] [Related] [Next] [New Search]